Predict your next investment

Asset/Investment Management

See what CB Insights has to offer

Investments

1

About Sage Partners

Sage Partners is an investment firm in Hong Kong.

Sage Partners Headquarter Location

Hong Kong

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Sage Partners News

Visus Therapeutics lands $20M to develop eye drop that corrects vision loss

Aug 13, 2021

Visus Therapeutics, a Seattle-based startup developing a presbyopia-correcting eye drop, raised $20 million.The fresh cash comes just six months after the company raised $36 million.Backers in this round include LSP, Sage Partners, Johnson & Johnson Innovation, and others.The company’s lead asset, BRIMOCHOL, is a once-daily eye drop that aims to treat presbyopia, a vision condition caused by aging that can make tasks such as reading difficult.Founded in 2019, Visus is led by CEO Ben Bergo, who previously co-founded Lumos Diagnostics and Seattle-based Nohla Therapeutics. Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.

Sage Partners Investments

1 Investments

Sage Partners has made 1 investments. Their latest investment was in Visus Therapeutics as part of their Series A - II on August 8, 2021.

CBI Logo

Sage Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/10/2021

Series A - II

Visus Therapeutics

$20M

Yes

Johnson & Johnson Innovation, Life Sciences Partners, and Undisclosed Investors

3

Date

8/10/2021

Round

Series A - II

Company

Visus Therapeutics

Amount

$20M

New?

Yes

Co-Investors

Johnson & Johnson Innovation, Life Sciences Partners, and Undisclosed Investors

Sources

3

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.